Company / Revenue
TREACE MEDICAL CONCEPTS, INC. Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$187.1M
FY2025
5-year range
$39.4M / $187.1M
FY2021-FY2025
Trend
+31.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 4 consecutive years, from $39M in FY2021 to $187M in FY2025.
Based on SEC 10-K filings.
$187M in FY2025 with a 3-year CAGR of +48.3%.
Improved from $94M to $187M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +48.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TREACE MEDICAL CONCEPTS, INC.'s revenue has grown for 4 consecutive years.
- 3-year CAGR of +48.3%, indicating consistent growth.
- In FY2025, revenue increased 31.9% year-over-year.
- Lowest revenue in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $187.1M | +31.9% |
| FY2024 | $141.8M | +50.2% |
| FY2023 | $94.4M | +64.6% |
| FY2022 | $57.4M | +45.5% |
| FY2021 | $39.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026